METASTATIC BREAST CARCINOMA
Clinical trials for METASTATIC BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radiation drug aims to slow bone tumors in advanced cancer
Disease control Not yet recruitingThis early-phase study tests a new drug (Sn-117m-DTPA) that delivers low-level radiation directly to bone tumors while being gentler on bone marrow. It is for people with prostate, breast, or lung cancer that has spread to the bones. The main goals are to find the safest dose and…
Matched conditions: METASTATIC BREAST CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 03:20 UTC
-
New radiation therapy aims to shrink advanced breast tumors
Disease control Not yet recruitingThis early-phase study tests a drug called 177Lu-DOTATATE in 10 people with stage IV or recurrent breast cancer. The drug targets cancer cells that have a specific marker (SSTR2) and delivers radiation to kill them. The goal is to see if it can shrink tumors and reduce cancer ste…
Matched conditions: METASTATIC BREAST CARCINOMA
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated May 26, 2026 03:05 UTC